Eisai
4523.T
#1927
Rank
A$13.02 B
Marketcap
$46.20
Share price
0.67%
Change (1 day)
-41.83%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Eisai (4523.T) - Total debt

Total debt on the balance sheet as of March 2024 : A$1.61 Billion

According to Eisai's latest financial reports the company's total debt is A$1.61 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Eisai - Total debt on balance sheet (from 2009 to 2024)

Total debt by year

Year Total debt Change
2023-03-31A$1.40 B35.99%
2022-03-31A$1.03 B-3.23%
2021-03-31A$1.07 B-20.63%
2020-03-31A$1.34 B-23.58%
2019-03-31A$1.76 B-16.7%
2018-03-31A$2.11 B-15.03%
2017-03-31A$2.49 B5.49%
2016-03-31A$2.36 B-7.93%
2015-03-31A$2.56 B-1.01%
2014-03-31A$2.59 B-18.86%
2013-03-31A$3.19 B-20.33%
2012-03-31A$4.01 B-9.33%
2011-03-31A$4.42 B-7.5%
2010-03-31A$4.78 B-22.29%
2009-03-31A$6.15 B35.81%
2008-03-31A$4.53 B182730.31%
2007-03-31A$2.48 M-50.08%
2006-03-31A$4.96 M-50.67%
2005-03-31A$10.07 M314.1%
2004-03-31A$2.43 M394.79%
2003-03-31A$0.49 M-99.47%
2002-03-31A$91.9 M-28.95%
2001-03-31A$0.12 B-55.54%
2000-03-31A$0.29 B